IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 10 holdings | $18.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$18.1M1,915,27499.2%
Misonix, Inc.(MSON)COM604871103$31.6K1,695,9690.2%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$30.6K1,719,5760.2%
Avrobio IncCOM05455M100$28.5K1,417,2040.2%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$28.0K449,9510.2%
Sutro Biopharma IncCOM869367102$20.1K1,824,5420.1%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$3.3K311,4900.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$2.5K628,2360.0%
Catabasis Pharmaceuticals in(CATBEUR)COM NEW14875P206$1.7K285,7650.0%
Transenterix IncCOM NEW89366M201$750510,1420.0%